Vitamin D in Cancer Prevention: Gaps in Current Knowledge and Room for Hope

Area of Science:

• Molecular Biology
• Cancer Research
• Nutritional Science

Background:

• Epigenome and transcriptome analyses reveal vitamin D's role in cell regulation and immune response, suggesting a link to cancer risk.
• Population studies associate low vitamin D levels with increased cancer incidence.
• Clinical trials with cholecalciferol supplementation have not consistently demonstrated cancer prevention benefits.

Purpose of the Study:

• To reconcile the discrepancy between observational data and clinical trial outcomes regarding vitamin D and cancer prevention.
• To critically review existing literature, focusing on study design, conduct, and analysis limitations.
• To explore the dose-response relationship of vitamin D and interindividual variability in response to supplementation.

Main Methods:

• Comprehensive literature review and critical assessment of randomized clinical trials and observational studies.
• Analysis of epigenetic and transcriptomic data to understand vitamin D's molecular mechanisms.
• Examination of the relationship between vitamin D levels, cholecalciferol, and calcitriol activity.

Main Results:

• Existing research presents conflicting evidence on vitamin D's role in cancer prevention.
• Limitations in study design and interpretation may obscure the true effects of vitamin D supplementation.
• Significant interindividual variability exists in epigenetic and transcriptomic responses to cholecalciferol.

Conclusions:

• The potential of vitamin D in cancer prevention remains unclear due to inconsistent trial results and methodological challenges.
• Further research is needed to elucidate optimal vitamin D thresholds and personalized supplementation strategies.
• A holistic approach combining tailored vitamin D interventions with healthy lifestyle choices is recommended for cancer prevention.